Provide the service and the quality care you truly deserve. Incorporate current research, medical science, and new technology into my practice, thus providing my patients with safe and effective treatment options. Provide education to my patients so that they understand the disease and the treatment involved. Incorporate the best knowledge of nutritional sciences into my clinical practice.
Muhammad Sheikh, M.D. has served as the founding Chief of the Gastroenterology and Hepatology program at UCSF Fresno. He was instrumental in the creation and accreditation of a new gastroenterology division and fellowship program at UCSF Fresno. He is Professor (emeritus) of Clinical Medicine, University of California San Francisco (UCSF). Dr. Sheikh is board certified in Internal Medicine, Gastroenterology and Clinical Nutrition. In addition, he specializes in hepatology and the management of liver diseases, liver transplant evaluation, and the nutritional support of critically ill patients. Dr. Sheikh is actively involved in clinical research as it relates to hepatitis C, fatty liver, and hepatic encephalopathy. Dr. Sheikh completed his residency training at Indiana University and his fellowship training at the University of Louisville in Kentucky and Beth Israel Deaconess Medical Center, Harvard Medical School in Boston. Dr. Sheikh is listed as one of the best Gastroenterologists in the United States by Consumer Reports and is a fellow of the American College of Physicians (ACP), American College of Gastroenterology (ACG) and the American Gastroenterology Association (AGA). He has been selected for "Who's Who" 2010/2011 edition as a member of North America's most accomplished Healthcare Professionals. He directs "Valley Gut Club", a highly prestigious monthly Continuing Medical Education program in the Central California. Dr. Sheikh is the recipient of "Laureate Award-2012 "from American College of Physicians, Northern California Chapter. Dr. Sheikh has published extensively in top ranking journals including: The New England Journal of Medicine and Hepatology. He is presently actively involved in clinical trials related to non-alcoholic steatohepatitis (NASH). He is president of Fresno Clinical Research Center (FCRC).